UNIVERSAL IBOGAINE INCUNIVERSAL IBOGAINE INCUNIVERSAL IBOGAINE INC

UNIVERSAL IBOGAINE INC

No trades
See on Supercharts
Market capitalization
‪2.05 M‬CAD
−0.005CAD
‪−2.39 M‬CAD
‪1.03 M‬CAD
‪139.64 M‬
Beta (1Y)
−1.61

About UNIVERSAL IBOGAINE INC

CEO
Nicholas Peter Karos
Headquarters
Calgary
Founded
2018
FIGI
BBG00GFL2NZ0
Universal Ibogaine, Inc. engages in developing ibogaine based drug franchise to treat addiction and related mental health issues. The company was founded by Shayne Nyquvest and Alberto Solá Agulló in 2018 and is headquartered in Calgary, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of IBO is 0.015 CAD — it hasn't changed in the past 24 hours. Watch UNIVERSAL IBOGAINE INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange UNIVERSAL IBOGAINE INC stocks are traded under the ticker IBO.
IBO stock hasn't changed in a week, the last month showed zero change in price, over the last year UNIVERSAL IBOGAINE INC has showed a 25.00% decrease.
IBO reached its all-time high on Sep 20, 2017 with the price of 0.340 CAD, and its all-time low was 0.005 CAD and was reached on Sep 20, 2023. View more price dynamics on IBO chart.
See other stocks reaching their highest and lowest prices.
IBO stock is 50.00% volatile and has beta coefficient of −1.61. Track UNIVERSAL IBOGAINE INC stock price on the chart and check out the list of the most volatile stocks — is UNIVERSAL IBOGAINE INC there?
Today UNIVERSAL IBOGAINE INC has the market capitalization of ‪2.37 M‬, it has decreased by 50.00% over the last week.
Yes, you can track UNIVERSAL IBOGAINE INC financials in yearly and quarterly reports right on TradingView.
IBO net income for the last quarter is ‪−222.20 K‬ CAD, while the quarter before that showed ‪−207.85 K‬ CAD of net income which accounts for −6.90% change. Track more UNIVERSAL IBOGAINE INC financial stats to get the full picture.
No, IBO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UNIVERSAL IBOGAINE INC EBITDA is ‪−473.09 K‬ CAD, and current EBITDA margin is −170.36%. See more stats in UNIVERSAL IBOGAINE INC financial statements.
Like other stocks, IBO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UNIVERSAL IBOGAINE INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So UNIVERSAL IBOGAINE INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating UNIVERSAL IBOGAINE INC stock shows the sell signal. See more of UNIVERSAL IBOGAINE INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.